Main features of patients with fulminant hepatic failure according to the presence or absence of HGV RNA sequences in serum
| HGV RNA | |||
| Total (n=68) | Present (n=13) | Absent (n=55) | |
| Age (y) | 30 (13) | 29 (11) | 30 (14) |
| Sex (M/F) | 32/36 | 8/5 | 24/31 |
| Presumed source of infection | |||
| Intravenous drug abuse | 18 | 6 (33%) | 12 (66%) |
| Sexual | 11 | 3 (27%) | 8 (73%) |
| Unknown | 39 | 4 (10%) | 35 (90%) |
| Presumed aetiology | |||
| HAV | 3 | 0 | 3 (100%) |
| HBV | 25 | 6 (24%) | 19 (76%) |
| HBV/HDV | 12 | 5 (42%) | 7 (58%) |
| HCV | 2 | 0 | 2 (100%) |
| Miscellaneous non-viral | 7 | 0 | 7 (100%) |
| Idiopathic | 19 | 2 (11%) | 17 (89%) |
| Clinical presentation | |||
| Hyperacute | 26 | 4 (15%) | 22 (85%) |
| Acute | 30 | 4 (13%) | 26 (87%) |
| Subacute | 12 | 5 (42%) | 7 (58%) |
| Final outcome | |||
| Recovery | 9 | 4 (44%) | 5 (56%) |
| Death | 21 | 5 (24%) | 16 (76%) |
| Liver transplantation | 38 | 4 (11%) | 34 (89%) |